Key references: Bisphosphonates for Paget disease of bone

  • Gutteridge DH, Retallack RW, Ward LC, Stuckey BG, Stewart GO, Prince RL, et al. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. Bone 1996;19(4):387–94. https://www.ncbi.nlm.nih.gov/pubmed/8894145
  • Reid IR, Lyles K, Su G, Brown JP, Walsh JP, del Pino-Montes J, et al. A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. J Bone Miner Res 2011;26(9):2261–70. https://www.ncbi.nlm.nih.gov/pubmed/21638319
  • Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, et al. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med 2005;353(9):898–908. https://www.ncbi.nlm.nih.gov/pubmed/16135834
  • Singer FR, Bone HG, Hosking DJ, Lyles KW, Murad MH, Reid IR, et al. Paget's disease of bone: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014;99(12):4408–22. https://www.ncbi.nlm.nih.gov/pubmed/25406796